Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
2018 · Cancer Discovery · 1,051 citations
https://doi.org/10.1158/2159-8290.cd-18-0349
R
Rashesh Sanghvi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
2.4K
Citations
15
h-index
19
i10-index
Rashesh Sanghvi is an academic researcher from Wellcome Sanger Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Pancreatic and Hepatic Oncology Research & Epigenetics and DNA Methylation. The author has an h-index of 15, co-authored 51 publications.
ORCID: 0000-0002-7703-9216Papers by this author
worksA recurrent novel <i>MGA–NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcoma
2018 · Molecular Case Studies · 52 citations
https://doi.org/10.1101/mcs.a003194
Human genome meeting 2016
2016 · Human Genomics · 41 citations
https://doi.org/10.1186/s40246-016-0063-5
Human genome meeting 2016
2016 · Human Genomics · 41 citations
https://doi.org/10.1186/s40246-016-0063-5
Clonal diversification and histogenesis of malignant germ cell tumours
2022 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-022-31375-4
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
2024 · The Lancet Oncology · 8 citations
https://doi.org/10.1016/s1470-2045(24)00598-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat